"Many companies have relocated manufacturing to India and China, cutting labor costs..."
That reinforces the notion that price erosion (for Western generics producers) is here to stay in the generics sector, although I'm not sure how labour-intensive the production process is and how significant that cost-cutting might be.
However, there is one saving grace:
(on moving production to cheaper jurisdictions) "....but creating new problems with quality and oversight".
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.25 |
Change
0.000(0.00%) |
Mkt cap ! $426.5M | |||
| Open | High | Low | Value | Volume |
| $5.25 | $5.30 | $5.18 | $1.126M | 214.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9347 | $5.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.28 | 2000 | 2 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |